ACUNETX’S CEO FOCUS OF LOS ANGELES BUSINESS JOURNAL ARTICLE

TORRANCE, CA., November 12, 2007 – AcuNetx, Inc. (OTCBB: ANTX), announced today  that its president and CEO, Ron Waldorf,  was the subject of a full-page feature  article appearing in the November 12-18, 2007 edition of the Los Angeles Business  Journal (www.labusinessjournal.com).  The article looks at Mr. Waldorf’s evolution  as an entrepreneur, while discussing product development and marketing that is  fueling the company’s growth and success.  Commenting on the article Mr. Waldorf stated “That a major publication like the  LA Business Journal should write an article around our company, effectively argues  that our contribution to the advancement of non-invasive medical systems and  diagnostic tools is being recognized.  Coming on the heels of The Innovation Award  for the company’s law enforcement product – HawkEye™ (See November 8, 2007, press release),  it affirms our belief that the company’s future is bright and that our hard work is  producing concrete results.” 


About AcuNetx, Inc.
AcuNetx markets a diverse line of diagnostic, analytical and therapeutic tools  for medical (audiologist, neurologists, otolaryngologists and physical therapists  as well as hospitals, clinics, and  extended care facilities) and law enforcement  applications.  AcuNetx is headquartered in Torrance, CA.  For more information  concerning AcuNetx and its subsidiaries, please visit  www.acunetx.com


FOR FURTHER INFORMATION CONTACT:
Name: J. Astor
G.M. Astor & Associates
Telephone: 818 788 4346
gastor@acunetx.com
 
Safe Harbor for Forward-Looking Statements

This news release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company’s operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are set forth in the company’s periodic filings with the U.S. Securities and Exchange Commission.